Navigation Links
CTRC-AACR San Antonio Breast Cancer Symposium continues to expand
Date:12/3/2009

PHILADELPHIA Now in its 32nd year, the CTRC-AACR San Antonio Breast Cancer Symposium continues to attract the best in breast cancer science and world leaders from industry and academia with the goal of eradicating breast cancer.

This year, more than 8,500 scientists and other professionals will gather at the Henry B. Gonzales Convention Center in San Antonio from Dec. 9-13, 2009. The symposium is a partnership between the American Association for Cancer Research, the University of Texas Health Science Center and Baylor College of Medicine.

Last year, more than 8,000 people attended from 92 countries; 46 percent of the participants were medical doctors and 9 percent were basic research scientists. Last year was the first year the AACR partnered with the symposium in an effort to help increase the presence of basic science. As a result, the meeting began one day earlier than in past years and held standing room only scientific sessions.

"The San Antonio Breast Cancer Symposium is arguably the best cancer research meeting in the world, and with the addition of high quality science, credibility and outreach efforts from the American Association for Cancer Research, this collaboration continues to garner further scientific prominence," said C. Kent Osborne, M.D., director of the Dan L. Duncan Center and the Lester and Sue Smith Breast Center at Baylor College of Medicine and president of the symposium.

This year, in addition to the main program, the CTRC-AACR-SABCS press office will host four press conferences for the media highlighting important news from the meeting and a separate media Q&A on December 12 at 10:00 a.m. CT with Dennis Slamon, M.D., Ph.D. on the long-term survival, disease free survival and cardiac toxicity results from his latest research with Herceptin.

The following is a schedule of the press briefings.

  • Bisphosphonates: 12:30 p.m. CT, Thursday, Dec. 10
  • Drugs in the Pipeline: 8:00 a.m. CT, Friday, Dec. 11
  • New Treatment Paradigms: 12:30 p.m. CT, Friday, Dec. 11
  • Patient Management and Prognosis: 8:00 a.m. CT, Saturday, Dec. 12
  • Media Q&A with Dennis Slamon, M.D., Ph.D, 10:00 a.m. CT, Saturday, Dec. 12

Beyond the press conferences, the press office has selected additional abstracts that may be of interest to the media and will be highlighting them as separate press releases.

AACR will be conducting interviews with researchers throughout the symposium. Recordings of these events and interviews will be posted to AACR Scientific Podcast feed. You can subscribe to this feed through following links:

AACR Scientific Podcast RSS Reader: http://feeds.feedburner.com/AacrScientificPodcasts

AACR RSS News Feed: http://feeds.feedburner.com/aacr


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
Source:Eurekalert

Related biology news :

1. CTRC-AACR San Antonio Breast Cancer Symposium
2. 31st Annual San Antonio Breast Cancer Symposium
3. Animal and biological science highlights: San Antonio Fluid Dynamics Conference, Nov. 23-25
4. UTSA wins San Antonio Area Foundation grant to further chlamydia research
5. UT San Antonio researcher wins $917,000 from NIH to study memory
6. Newly created cancer stem cells could aid breast cancer research
7. Linchpin gene may be useful target for new breast cancer therapies
8. Dietary calcium could possibly prevent the spread of breast cancer to bone
9. Researchers find new gene linked to breast cancer
10. Analysis of breast and colon cancer genes finds many areas of differences between tumors
11. Genome update defines landscape of breast and colon cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/3/2017)... , Feb. 3, 2017 A new ... Identity Strategy Partners, LLP (IdSP) . Designed to fill ... the complex identity market, founding partners Mark Crego ... 35 combined years just in identity expertise that span ... and non-profit leadership. The Crego-Kephart combined expertise has a ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... Biopharm Reports has carried out a ... nuclear magnetic resonance spectroscopy (NMR). This involved the ... practices, developments, trends and end-user plans over the ... opportunities. These areas include growth in the use ... innovation requirements, hyphenated NMR techniques, main suppliers of ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017  Capricor Therapeutics, Inc. (NASDAQ: CAPR), a ... conditions, today announced that Linda Marbán, Ph.D, president and chief ... conferences: Cowen and Company 37th Annual ... ET Boston, MA ... am PT (12:00 pm ET) Dana Point, CA ...
(Date:2/22/2017)... CA (PRWEB) , ... February 22, 2017 , ... ... announced that is has acquired Kendall Research Systems, LLC (KRS) clinical ... (MIT) that develops neural interface technology for research and clinical applications. The terms ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... development of precision treatments for neurodegenerative diseases, today announced it has issued a ... approach.” This is one of a series of commentaries from ProMIS’s scientific team ...
(Date:2/22/2017)... Feb. 22, 2017 Aethlon Medical, Inc. (Nasdaq: ... a study that validated the ability of the Aethlon ... with increased mortality in immune-suppressed sepsis patients and also ... The objective of the study was to validate ... Epstein-Barr virus (EBV) and Herpes Simplex virus 1 (HSV1) ...
Breaking Biology Technology: